Charles Schwab’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-120,880
Closed -$738K 3623
2021
Q3
$738K Sell
120,880
-195,445
-62% -$1.22M ﹤0.01% 2994
2021
Q2
$2.6M Buy
316,325
+14,470
+5% +$123K ﹤0.01% 2623
2021
Q1
$2.7M Buy
301,855
+5,709
+2% +$65.4K ﹤0.01% 2571
2020
Q4
$3.42M Buy
296,146
+4,665
+2% +$54.2K ﹤0.01% 2402
2020
Q3
$3.04M Buy
291,481
+25,102
+9% +$308K ﹤0.01% 2322
2020
Q2
$3.5M Buy
266,379
+56,807
+27% +$589K ﹤0.01% 2196
2020
Q1
$1.65M Buy
209,572
+3,616
+2% +$54.5K ﹤0.01% 2335
2019
Q4
$4.26M Buy
205,956
+5,019
+2% +$84.6K ﹤0.01% 2098
2019
Q3
$2.75M Buy
200,937
+6,135
+3% +$72.8K ﹤0.01% 2267
2019
Q2
$2.4M Buy
194,802
+6,906
+4% +$79.7K ﹤0.01% 2309
2019
Q1
$2.35M Buy
187,896
+5,489
+3% +$73.3K ﹤0.01% 2309
2018
Q4
$2.06M Sell
182,407
-1,362
-0.7% -$21.4K ﹤0.01% 2324
2018
Q3
$3.44M Buy
183,769
+4,111
+2% +$94.5K ﹤0.01% 2238
2018
Q2
$4.64M Buy
179,658
+5,257
+3% +$136K ﹤0.01% 2041
2018
Q1
$3.91M Buy
174,401
+9,179
+6% +$224K ﹤0.01% 2065
2017
Q4
$4.14M Buy
165,222
+57,672
+54% +$1.41M ﹤0.01% 2021
2017
Q3
$2.6M Buy
107,550
+6,336
+6% +$149K ﹤0.01% 2194
2017
Q2
$2.05M Buy
101,214
+513
+0.5% +$10.7K ﹤0.01% 2215
2017
Q1
$2.71M Buy
100,701
+4,617
+5% +$94.3K ﹤0.01% 2080
2016
Q4
$1.83M Buy
96,084
+23,258
+32% +$444K ﹤0.01% 2215
2016
Q3
$1.42M Buy
72,826
+43,883
+152% +$742K ﹤0.01% 2288
2016
Q2
$434K Buy
28,943
+9,000
+45% +$113K ﹤0.01% 2639
2016
Q1
$184K Hold
19,943
﹤0.01% 2915
2015
Q4
$385K Hold
19,943
﹤0.01% 2760
2015
Q3
$297K Hold
19,943
﹤0.01% 2832
2015
Q2
$437K Buy
+19,943
New +$402K ﹤0.01% 2721